HK1220643A1 - 具有提高穩定性的抗血栓/殺菌 -亞硝基- -乙酰基青霉胺 摻雜氧化氮釋放聚合物 - Google Patents

具有提高穩定性的抗血栓/殺菌 -亞硝基- -乙酰基青霉胺 摻雜氧化氮釋放聚合物

Info

Publication number
HK1220643A1
HK1220643A1 HK16108605.2A HK16108605A HK1220643A1 HK 1220643 A1 HK1220643 A1 HK 1220643A1 HK 16108605 A HK16108605 A HK 16108605A HK 1220643 A1 HK1220643 A1 HK 1220643A1
Authority
HK
Hong Kong
Prior art keywords
snap
thromboresistant
acetylpenicillamine
nitroso
bactericidal
Prior art date
Application number
HK16108605.2A
Other languages
English (en)
Inventor
Elizabeth J Brisbois
Hitesh Handa
Mark E Meyerhoff
Original Assignee
Univ Michigan Regents
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan Regents filed Critical Univ Michigan Regents
Publication of HK1220643A1 publication Critical patent/HK1220643A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0076—Chemical modification of the substrate
    • A61L33/0082—Chemical modification of the substrate by reacting with an organic compound other than heparin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0076—Chemical modification of the substrate
    • A61L33/0088—Chemical modification of the substrate by grafting of a monomer onto the substrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/04—Use of organic materials, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18—Manufacture of films or sheets
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
    • C08J7/02—Chemical treatment or coating of shaped articles made of macromolecular substances with solvents, e.g. swelling agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
    • C08J7/04—Coating
    • C08J7/046—Forming abrasion-resistant coatings; Forming surface-hardening coatings
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
    • C08J7/04—Coating
    • C08J7/06—Coating with compositions not containing macromolecular substances
    • C08J7/065—Low-molecular-weight organic substances, e.g. absorption of additives in the surface of the article
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/114—Nitric oxide, i.e. NO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2375/00—Characterised by the use of polyureas or polyurethanes; Derivatives of such polymers
    • C08J2375/04—Polyurethanes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2383/00—Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen, or carbon only; Derivatives of such polymers
    • C08J2383/04—Polysiloxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Manufacturing & Machinery (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Materials For Medical Uses (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • External Artificial Organs (AREA)
  • Laminated Bodies (AREA)
HK16108605.2A 2013-02-07 2016-07-20 具有提高穩定性的抗血栓/殺菌 -亞硝基- -乙酰基青霉胺 摻雜氧化氮釋放聚合物 HK1220643A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361762013P 2013-02-07 2013-02-07
PCT/US2014/015086 WO2014124125A2 (en) 2013-02-07 2014-02-06 Thromboresistant/bactericidal s-nitroso-n-acetylpenicillamine (snap)-doped nitric oxide release polymers with enhanced stability

Publications (1)

Publication Number Publication Date
HK1220643A1 true HK1220643A1 (zh) 2017-05-12

Family

ID=51300259

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16108605.2A HK1220643A1 (zh) 2013-02-07 2016-07-20 具有提高穩定性的抗血栓/殺菌 -亞硝基- -乙酰基青霉胺 摻雜氧化氮釋放聚合物

Country Status (7)

Country Link
US (2) US11103622B2 (zh)
EP (3) EP3673928B1 (zh)
JP (2) JP2016514171A (zh)
CN (2) CN105307695B (zh)
CA (1) CA2899477C (zh)
HK (1) HK1220643A1 (zh)
WO (2) WO2014124125A2 (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008143889A1 (en) 2007-05-14 2008-11-27 Research Foundation Of State University Of New York Induction of a physiological dispersion response in bacterial cells in a biofilm
EP3673928B1 (en) * 2013-02-07 2021-06-30 The Regents Of The University Of Michigan Thromboresistant/bactericidal s-nitroso-n-acetylpenicillamine (snap)-doped nitric oxide release polymers with enhanced stability
GB201506236D0 (en) * 2015-04-13 2015-05-27 Jellagen Pty Ltd Modified collagen, methods of manufacture thereof
ES2899364T3 (es) * 2016-02-25 2022-03-11 Univ Michigan Regents Formulaciones y kits generadores de óxido nítrico
US20190358368A1 (en) * 2016-12-16 2019-11-28 University Of Georgia Research Foundation, Inc. Nitric oxide releasing slippery surfaces for decreased fouling, thrombosis, and infection of medical devices
CN110446521B (zh) 2017-01-21 2022-05-06 生物克瑞德公司 配置用于一氧化氮的控制释放的医疗产品和方法
US10709360B2 (en) * 2017-09-02 2020-07-14 Biocrede Inc. Medical device with integrated biosensor
WO2019079765A1 (en) * 2017-10-20 2019-04-25 University Of Georgia Research Foundation, Inc. SURFACES AND COATING COMPOSITIONS COMPRISING ANTIFOULING, ANTITHROMBOTIC AND ANTIBACTERIAL PROPERTIES AND METHODS OF PREPARATION THEREOF
US20190231936A1 (en) * 2018-02-01 2019-08-01 Biocrede, Inc. Method of making thromboresistant/bactericidal s-nitroso-n-acetylpenicillamine (snap)-impregnated nitric oxide release polymers with enhanced stability
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
CN108926746A (zh) * 2018-07-11 2018-12-04 山西因美科技有限公司 一种抗感染医用导管的制备方法
CN112689518A (zh) * 2018-07-16 2021-04-20 乔治亚大学研究基金会 稳定的一氧化氮释放聚合物和制品及其制备方法和用途
EP3826628A4 (en) * 2018-08-24 2022-09-07 University of Georgia Research Foundation, Inc. PROSTHETIC VASCULAR GRAFTS WITH NON-REMOVABLE COATING
WO2020069368A1 (en) 2018-09-27 2020-04-02 The Regents Of The University Of Michigan Gas delivery devices
CN109897883B (zh) * 2019-04-02 2022-04-19 山西因美科技有限公司 一氧化氮释放聚合物在检测大肠杆菌中的应用
MX2021015189A (es) * 2019-06-10 2022-03-17 Univ Michigan Regents Dispositivos de inserción de catéteres.
US20210146014A1 (en) * 2019-11-18 2021-05-20 Becton, Dickinson And Company Nitric oxide and chlorhexidine releasing catheter for anti-platelet and antimicrobial dual functionality
EP4340899A1 (en) * 2021-05-19 2024-03-27 University of Georgia Research Foundation, Inc. Nitric oxide-releasing disinfection insert

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187305A (en) * 1990-11-26 1993-02-16 Glaxo Inc. S-nitroso-N-alkonoylpenicillamines
US6200558B1 (en) 1993-09-14 2001-03-13 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5665077A (en) 1995-04-24 1997-09-09 Nitrosci Pharmaceuticals Llc Nitric oxide-releasing nitroso compositions and methods and intravascular devices for using them to prevent restenosis
US6232434B1 (en) 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US5797887A (en) 1996-08-27 1998-08-25 Novovasc Llc Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation
US6171232B1 (en) 1997-06-26 2001-01-09 Cordis Corporation Method for targeting in vivo nitric oxide release
US5994444A (en) 1997-10-16 1999-11-30 Medtronic, Inc. Polymeric material that releases nitric oxide
US20020009498A1 (en) * 1999-11-05 2002-01-24 Guy L. Clifton Methods and compositions for treatment of traumatic brain injury
NZ519781A (en) * 1999-12-23 2004-04-30 Nitromed Inc Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
AU2001247579B2 (en) 2000-03-20 2005-01-06 Novovascular, Inc. Matrices containing nitric oxide donors and reducing agents and their use
US6780849B2 (en) 2000-12-21 2004-08-24 Scimed Life Systems, Inc. Lipid-based nitric oxide donors
US7128904B2 (en) 2001-01-16 2006-10-31 The Regents Of The University Of Michigan Material containing metal ion ligand complex producing nitric oxide in contact with blood
US6706274B2 (en) * 2001-01-18 2004-03-16 Scimed Life Systems, Inc. Differential delivery of nitric oxide
WO2004017939A1 (ja) * 2002-08-20 2004-03-04 Terumo Kabushiki Kaisha 体内埋込医療器具
BRPI0412273B1 (pt) 2003-07-03 2019-09-24 The University Court Of The University Of St. Andrews Preparação farmacêutica, uso de um material de zeólito, artigo médico, produto cosmético e/ou de higiene pessoal, e, método de liberação de óxido nítrico
US7829553B2 (en) 2004-02-09 2010-11-09 Amulet Pharmaceuticals, Inc. Nitric oxide-releasing polymers
US20060039950A1 (en) * 2004-08-23 2006-02-23 Zhengrong Zhou Multi-functional biocompatible coatings for intravascular devices
BRPI0503201B8 (pt) 2005-07-28 2021-05-25 Sci Tech Produtos Medicos Ltda stents revestidos com blendas poliméricas hidrofílicas, eluidoras de óxido nítrico e s-nitrosotióis
CA2632224A1 (en) * 2005-12-02 2007-06-07 The Regents Of The University Of Michigan Polymer compositions, coatings and devices, and methods of making and using the same
US20070148251A1 (en) 2005-12-22 2007-06-28 Hossainy Syed F A Nanoparticle releasing medical devices
EP2001923B1 (en) * 2006-03-31 2013-09-25 Aortech International plc Biostable polyurethanes
WO2007149520A2 (en) 2006-06-21 2007-12-27 Albert Einstein College Of Medicine Of Yeshiva University Compositions for sustained release of nitric oxide, methods of preparing same and uses thereof
US8062656B2 (en) 2007-04-18 2011-11-22 Central Michigan University Methods of treating disease with nitric oxide (NO)-releasing polymers and soluble no-releasing nitrosamines
CA2599082A1 (en) 2007-08-27 2009-02-27 Ping I. Lee Supramacromolecular polymer complexes providing controlled nitric oxide release for healing wounds
WO2009124379A1 (en) 2008-04-09 2009-10-15 Enox Biopharma, Inc. Biofilm-inhibiting catheters and tubings
WO2009131931A1 (en) 2008-04-21 2009-10-29 3M Innovative Properties Company Nitric oxide-releasing compositions, devices and methods
CN104017193B (zh) 2008-09-19 2018-04-24 西北大学 产生一氧化氮的生物可降解聚合物和相关生物医学装置
US8735354B2 (en) 2008-11-07 2014-05-27 Uab Research Foundation Endothelium mimicking nanomatrix
US9278113B2 (en) 2009-03-30 2016-03-08 The Board Of Regents, The University Of Texas System Titanium dioxide nanotubes for production and delivery of nitric oxide and methods for production thereof
DK2467173T3 (da) * 2009-08-21 2019-07-29 Novan Inc Sårbandager, fremgangsmåder til anvendelse heraf og fremgangsmåder til dannelse deraf
WO2011127181A2 (en) * 2010-04-06 2011-10-13 Syracuse University System and method for the release of nitric oxide using nanoscale media
CN102397597A (zh) * 2010-09-14 2012-04-04 深圳光启高等理工研究院 一种一氧化氮供体气血交换装置
ES2695173T3 (es) 2011-02-28 2019-01-02 Novan Inc Partículas de sílice modificadas con S-nitrosotiol que liberan óxido nítrico y procedimientos de fabricación de las mismas
EP3673928B1 (en) * 2013-02-07 2021-06-30 The Regents Of The University Of Michigan Thromboresistant/bactericidal s-nitroso-n-acetylpenicillamine (snap)-doped nitric oxide release polymers with enhanced stability

Also Published As

Publication number Publication date
US11103622B2 (en) 2021-08-31
EP3102240A1 (en) 2016-12-14
EP3673928B1 (en) 2021-06-30
EP2953660A4 (en) 2016-09-21
US20170028106A1 (en) 2017-02-02
JP2016514171A (ja) 2016-05-19
CA2899477C (en) 2019-09-17
JP2019093208A (ja) 2019-06-20
EP2953660B1 (en) 2020-04-01
WO2014124125A2 (en) 2014-08-14
WO2015119678A1 (en) 2015-08-13
EP2953660A2 (en) 2015-12-16
EP3673928A1 (en) 2020-07-01
EP3102240A4 (en) 2017-11-01
CN106456785A (zh) 2017-02-22
WO2014124125A3 (en) 2015-01-15
JP6763988B2 (ja) 2020-09-30
CA2899477A1 (en) 2014-08-14
CN105307695A (zh) 2016-02-03
US20150366831A1 (en) 2015-12-24
CN105307695B (zh) 2017-07-18

Similar Documents

Publication Publication Date Title
HK1220643A1 (zh) 具有提高穩定性的抗血栓/殺菌 -亞硝基- -乙酰基青霉胺 摻雜氧化氮釋放聚合物
GB2510655B (en) Prioritizing instructions based on type
PL2984138T3 (pl) Kompozycja polimerowa
SG11201510679RA (en) Fall arrester
ZA201604585B (en) Multistage polymers and compositions thereof
PL2954019T3 (pl) Kleje przeciwbakteryjne o ulepszonych właściwościach
IL241355B (en) Pyrazole-amide compounds, preparations containing them and their uses
EP3064388A4 (en) BATTERY PROTECTION STRUCTURE
EP2820862A4 (en) CONNECTING TERMINAL DEVICES
EP2968569A4 (en) COUGAR FORMULATION
EP2961788A4 (en) NANOPARTICLES STABILIZED WITH NITROPHENYLBORIC ACID COMPOSITIONS
HK1219227A1 (zh) 含氫的抗菌劑
EP2953455A4 (en) ANTIMICROBIAL COMPOSITIONS, WIPES AND METHODS
ZA201906057B (en) Formulations with reduced oxidation
EP2968620A4 (en) POLYMERIC COMPOSITIONS HAVING ENHANCED RADIO-OPACITY
IL242195B (en) Dicarboxylic acid compounds, preparations containing them and their uses
SI3060256T1 (sl) Nova stabilna formulacija
HK1214531A1 (zh) 穩定的靜脈內製劑
EP3048923B8 (fr) Dispositif de protection a mecanisme de symetrie
HUE062405T2 (hu) Antimikrobiális készítmény
EP2956409A4 (en) CATALYTIC ZINC OXIDE
ZA201506047B (en) Synchronous-generator pole stack
RS60534B1 (sr) Formulacije sa smanjenom oksidacijom
GB2523955B (en) Terminal
EP2851943A4 (en) MEMORY DEVICE AND MEMORY ELEMENT